Drug Topics
OCTOBER 9, 2024
On October 3,2024, Texas Attorney General Ken Paxton issued the lawsuit, which involves Eli Lilly, Express Scripts, CVS Pharmacy, and other pharmaceutical entities.
Pharmacy Is Right For Me
OCTOBER 9, 2024
Hello everyone, my name is Diana Martinez-Nava and I am a fourth-year student pharmacist at The University of New Mexico College of Pharmacy. I would like to take some time on this special month celebrating our Hispanic Heritage to share my story on my pharmacy journey. My interest in becoming a pharmacist began around the time I was 8 years old. I was that small child who could barely see over the counter at our neighborhood pharmacy next to my father’s arm who would be reaching out to collect,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 9, 2024
In an installment of Drug Topics’ 5 Questions With a Pharmacist, Anthony Minniti of Bell Pharmacy in Camden, New Jersey, discussed pharmacy in his community and the challenges that come with it.
STAT
OCTOBER 9, 2024
Newly published data show that seven out of 67 children who received Bluebird Bio’s gene therapy for a devastating neurological disorder in clinical trials have since gone on to develop blood cancers. That means four additional patients have developed blood cancers since June 2022, when concerns about three cancer cases prompted the Food and Drug Administration to hold a hearing of outside advisers before approving the treatment, marketed as Skysona.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 9, 2024
Current rules governing lawsuits must be revisited to strike a balance between legitimate and frivolous legal actions against health care providers.
STAT
OCTOBER 9, 2024
Two of the first efforts to treat Duchenne muscular dystrophy with CRISPR gene editing are getting off the ground in China, even as projects in the U.S. have seemingly stalled. Trials for the fatal muscle-wasting disease were started in the last couple of months by two different Chinese companies. One, GenAssist, has already dosed one young boy. Huidagene, the other biotech, expects to dose the first of three boys soon and report data by Q1 next year.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 9, 2024
LONDON — A trio of scientists who opened new doors in our understanding of the structure of proteins — the fundamental building blocks of biology — and even came up with ways to create new proteins won the Nobel Prize in chemistry Wednesday. The prize went to David Baker of the University of Washington, and to Demis Hassabis and John Jumper, who work at Google DeepMind in London.
Drug Topics
OCTOBER 9, 2024
Research Presented at CHEST 2024 reported on how mepolizumab can improve asthma control, and reduce exacerbations of concurrent asthma and COPD.
STAT
OCTOBER 9, 2024
Hospitals across the country are struggling to conserve and stretch their supplies of IV fluids in the wake of a shortage brought on by Hurricane Helene, in some cases giving patients Gatorade instead of IVs and warning the issue could lead to delays in elective medical procedures in the near future. A Baxter facility in North Carolina that produces more than half the nation’s IV solutions was forced to close after Helene, while Hurricane Milton is now bearing down on Florida, where a pla
Fierce Healthcare
OCTOBER 9, 2024
Reports of recent cyberattacks and disruptions in patient care have ticked up among healthcare organizations since 2023, with the average attack bringing just under $1.5 million in operational disr | Ninety-two percent of polled healthcare IT and security practitioners said their organization had faced at least once cyberattack during the prior year.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 9, 2024
WASHINGTON — A new report from congressional budget experts this week estimated that it would cost Medicare an additional $35 billion over nine years if the program began covering GLP-1 drugs for obesity. But the report also noted that half of seniors who would qualify for obesity coverage already have access to the drugs for other conditions.
Pharmacy Times
OCTOBER 9, 2024
The analysis assessed the feasibility of autologous transplantation of chemically-induced pluripotent stem cell-derived islets for type 1 diabetes.
STAT
OCTOBER 9, 2024
In the last year, pharma incumbents have leaned into partnerships with AI-driven startups to supercharge drug discovery efforts. High-powered models of protein structure and molecule binding can help identify new disease targets, and even help design new drugs. But AI-derived or not, a new drug candidate still has to wind its way through the painstaking clinical trial process.
Fierce Healthcare
OCTOBER 9, 2024
The Centers for Medicare & Medicaid Services (CMS) released a list of prescription drugs it hopes to include in its new Medicare $2 Drug List Model, the agency announced Wednesday. | CMS is looking to further refine its new Medicare $2 Drug List Model to make prices more predictable for Part D beneficiaries.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
OCTOBER 9, 2024
After protracted legal battling, GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac heartburn medication caused cancer. The settlement covers roughly 80,000 cases, or 93% of the suits that were outstanding in state courts around the U.S. At the same time, the company agreed to pay $70 million to settle a whistleblower lawsuit that was filed by Valisure, an independent laboratory that alleged GSK concealed the link between t
Drug Topics
OCTOBER 9, 2024
Drug Topics sat down with Benjamin Jolley, PharmD, of Jolley’s Compounding Pharmacy, to discuss the pharmacy industry and his experience in a myriad of roles within the profession.
STAT
OCTOBER 9, 2024
Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic diseases. But the deal is a little different compared to many recent deals between burgeoning artificial intelligence upstarts and established pharma giants: After identifying drug candidates, Insitro will be responsible for commercializing the drugs, and Lilly will be eligible for milestones and royalties.
Drug Topics
OCTOBER 9, 2024
Research presented at CHEST 2024 examined outcomes of COVID-19 on patients with alcoholic liver disease, cirrhosis, and non-alcohol steatohepatitis.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
OCTOBER 9, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning to everyone except the Empire State Building.
PharmaVoice
OCTOBER 9, 2024
Katelyn Jetelina, well known for her newsletter “Your Local Epidemiologist,” digs into the H5N1 outbreak, the public health response and what’s next for vaccinations.
pharmaphorum
OCTOBER 9, 2024
Advancing Precision Care For All with Hakim Yadi from Closed Loop Medicine. Listen to the latest podcast episode featuring insights from a leader in the healthcare industry.
Fierce Healthcare
OCTOBER 9, 2024
Amazon plans an aggressive expansion of its pharmacy business to offer same-day delivery of prescription medications to 20 new cities in 2025, which more than doubles its current operations. | Amazon plans an aggressive expansion of its pharmacy business to offer same-day delivery of prescription medications to 20 new cities in 2025, which more than doubles its current operations.
pharmaphorum
OCTOBER 9, 2024
Choosing the right POC (point of care) marketing partners in healthcare is crucial for reaching healthcare professionals (HCP) effectively. Learn about the importance and benefits of selecting the right partners in this essential marketing strategy.
STAT
OCTOBER 9, 2024
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is crème brûlée.
Pharmacy Times
OCTOBER 9, 2024
Two MUSC pharmacists describe how pharmacists are often the educational resource for patients and can help when removing certain barriers to care.
pharmaphorum
OCTOBER 9, 2024
The future of multiple myeloma treatment is personalised, but collaboration is essential to deliver it. Learn about the latest advancements and how working together can improve outcomes for patients.
Pharmacy Times
OCTOBER 9, 2024
The real-world study results of ciltacabtagene autoleucel are comparable to data from the CARTITUDE-1 trial, emphasizing its efficacy and safety.
Fierce Healthcare
OCTOBER 9, 2024
UnitedHealth Group, CVS Health and Cigna all submitted motions Oct. 8 to remove Lina Khan from the Federal Trade Commission’s ongoing antitrust lawsuit. | UnitedHealth, CVS Health and Cigna all view FTC chair Lina Khan as unfair toward PBMs and say she should be removed from the FTC's recently filed antitrust lawsuit.
Pharmacy Times
OCTOBER 9, 2024
The addition of high-dose vitamin D3 to standard treatment did not delay the progression of cancer compared with the standard dose of vitamin D3.
pharmaphorum
OCTOBER 9, 2024
Discover if healthcare professionals prefer the return of in-person meetings or are embracing virtual alternatives instead. Explore the benefits and challenges of virtual events for HCPs.
STAT
OCTOBER 9, 2024
Another ultra-rare therapy will soon be subject to the gaze of an FDA advisory committee, with the fate of more than 200 boys diagnosed with Barth syndrome worldwide in the balance. On Thursday, the FDA cardiovascular and renal drugs advisory committee will be reviewing a new drug application for elamipretide hydrochloride injection , submitted by Stealth BioTherapeutics Inc., for the treatment of Barth syndrome.
Pharmacy Times
OCTOBER 9, 2024
The discovery marks the first time an antibody has been observed to both assist and block viral infection with SARS-CoV-2.
STAT
OCTOBER 9, 2024
Good morning, it’s Wednesday! A few of us at STAT thought yesterday might have been Wednesday, but no, it’s today. And in case you’re as confused as us, tomorrow is Thursday. (You would think editing a weekly podcast keeps me aware of what day it is, but you’d be wrong.) There are only 11 weeks left in 2024 … ! Anyway, the news: Chemistry Nobel goes to three scientists for protein discoveries Scientists who opened new doors in our understanding of the structure
Expert insights. Personalized for you.
199 
Let's personalize your content